Doctors Note Logo

Published on: 10/1/2026

Eliquis 5 mg twice a day: side effects and bleeding warning signs

Eliquis (apixaban) 5 mg twice daily commonly causes easy bruising, nosebleeds, bleeding gums, minor cuts that bleed longer, and heavier menstrual bleeding, while the most serious risk is major internal bleeding. Warning signs that need urgent medical attention include red, pink or brown urine, black tarry or bloody stools, vomiting blood or material that looks like coffee grounds, coughing up blood, severe or sudden headache, dizziness, fainting, unusual weakness, confusion, vision changes, or any bleeding that will not stop. Risk increases with older age, kidney impairment, and combining Eliquis with NSAIDs, aspirin, other anticoagulants, or certain antifungals, antibiotics and seizure medicines; stopping the drug early can raise stroke risk, and spinal or epidural procedures carry a risk of spinal hematoma. There are several important factors to consider, including dose adjustments, timing of missed doses, and which symptoms mean call 911 versus call your prescriber, so review the complete answer below before deciding what to do.

If you are noticing new bruising, bleeding, headaches or weakness while taking Eliquis, it helps to sort out quickly whether this is an expected effect or an emergency, and a free, instant online symptom check can walk you through your specific symptoms in minutes and point you toward the right next step, whether that is monitoring at home, messaging your prescriber, or heading to urgent or emergency care.

Last reviewed for medical accuracy: 10/01/2026

answer background

Explanation

Side Effects of Eliquis 5 mg Twice a Day: What You Need to Know

Eliquis (apixaban) 5 mg taken twice daily is a common prescription anticoagulant used to reduce the risk of stroke and blood clots in conditions such as atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). While many patients tolerate it well, understanding the side effects of Eliquis 5 mg twice a day—especially signs of bleeding—is vital for your safety.

Why You’re Prescribed Eliquis 5 mg Twice a Day

Eliquis works by inhibiting Factor Xa, a key protein in the blood-clotting process. Your doctor may prescribe Eliquis 5 mg twice a day to:

  • Prevent stroke in non-valvular atrial fibrillation
  • Treat and prevent recurrence of DVT and PE
  • Lower clot risk after hip or knee replacement surgery

Taking the medication exactly as directed helps keep your blood thin enough to prevent clots but not so thin that you risk serious bleeding.

Common Side Effects

Most people taking Eliquis tolerate it well, but you may encounter mild or moderate reactions, including:

  • Bruising easily: Minor bumps or knocks may leave larger-than-normal bruises.
  • Minor bleeding: Nosebleeds, bleeding gums, or heavier menstrual flow in women.
  • Stomach upset: Nausea, indigestion, or mild gastrointestinal discomfort.
  • Fatigue: Feeling unusually tired or weak.
  • Headache: Generally mild and usually resolves on its own.

These side effects often improve after the first few weeks as your body adjusts. If they persist or bother you, talk with your doctor about possible dose adjustments or supportive remedies.

Less Common but Noticeable Effects

While less frequent, these reactions can occur. Keep an eye on:

  • Skin rash or itching
  • Dizziness or lightheadedness
  • Swelling of hands, feet, or ankles
  • Changes in liver tests (usually detected via routine bloodwork)
  • Shortness of breath

Report these symptoms to your healthcare provider, especially if they worsen or interfere with daily activities.

Serious Bleeding Warning Signs

The biggest concern with any blood thinner is excessive bleeding. Recognizing warning signs early can prevent complications:

  • Unusual bruising or bleeding that lasts longer than normal
  • Blood in urine or stools (pink, red, or dark brown color)
  • Coughing or vomiting blood (bright red or coffee-ground appearance)
  • Severe or persistent headache or weakness, which could indicate bleeding in the brain
  • Heavy menstrual bleeding that soaks through protection in an hour or less
  • Bleeding that won’t stop after applying pressure for 10 minutes

If you notice any of these, especially heavy bleeding or sudden weakness, seek medical care right away.

What to Do If You Experience Side Effects

  1. Stay calm. Mild side effects can improve on their own.
  2. Monitor closely. Keep a daily log of any bleeding, bruising, or unusual symptoms.
  3. Adjust activities. Avoid high-impact sports or tasks where cuts and bruises are likely.
  4. Report promptly. Contact your doctor or pharmacist if:
    • Bleeding is heavy or persistent
    • You develop new, severe symptoms
    • You have a fall or injury while on Eliquis

Tips for Reducing Bleeding Risk

Lifestyle changes and simple precautions can help minimize bleeding:

  • Use a soft toothbrush and electric razor to prevent gum and skin cuts.
  • Wear protective gear (helmets, pads) when cycling or playing contact sports.
  • Avoid over-the-counter NSAIDs (ibuprofen, naproxen) unless approved by your doctor.
  • Limit alcohol intake—alcohol can increase bleeding risk.
  • Keep emergency contact info and a list of medications in your wallet.

Drug and Food Interactions

Certain medicines and supplements can affect how Eliquis works. Always tell your healthcare team about everything you take, including:

  • Other blood thinners (warfarin, heparin)
  • Antiplatelet drugs (aspirin, clopidogrel)
  • Herbal products (St. John’s wort, ginkgo)
  • Antifungal or HIV medications (ketoconazole, ritonavir)

No specific foods need to be avoided, but maintaining a consistent diet and hydration level supports stable blood flow and reduces side-effect variability.

Monitoring and Follow-Up

  • Routine blood tests: Although Eliquis doesn’t require frequent INR checks like warfarin, your doctor may monitor kidney and liver function periodically.
  • Regular appointments: Discuss any new symptoms, changes in health, or other medications you start.
  • Emergency plan: Know where to go if you have severe bleeding or suspect a stroke.

When to Seek Immediate Help

If you or someone with you notices:

  • Sudden, severe headache or confusion
  • Trouble speaking, slurred speech, or weakness on one side
  • Difficulty breathing
  • Uncontrolled bleeding

Call emergency services right away. Time is critical in managing serious bleeding or stroke.

Free Symptom Check Option

If you have questions about a new symptom or aren’t sure whether it’s serious, you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to help guide your next steps.

Talking to Your Doctor

Always keep an open dialogue with your healthcare provider. Before making any changes—including stopping Eliquis 5 mg twice a day—discuss:

  • Any side effect that doesn’t improve or worsens
  • Plans for surgery or dental work (you may need to pause Eliquis short-term)
  • New medications or supplements
  • Pregnancy or breastfeeding

If you experience any potentially life-threatening or serious symptoms, seek medical attention immediately and inform your doctor.


Bottom Line: Taking Eliquis 5 mg twice a day can significantly reduce your risk of dangerous clots, but it carries a risk of bleeding. Familiarize yourself with both common and serious side effects, adopt protective habits, and stay in close contact with your healthcare team. If in doubt, use the Ubie Symptom Checker and always speak to a doctor about anything that could be life-threatening or serious.

(References)

  • * Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. Int Angiol. 2012 Aug;31(4):330-9. PMID: 22801398.

  • * Kono S, Yamashita T, Deguchi K, Omote Y, Yunoki T, Sato K, Kurata T, Hishikawa N, Abe K. Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat. Stroke. 2014 Aug;45(8):2404-10. doi: 10.1161/STROKEAHA.114.005316. Epub 2014 Jul 1. PMID: 24984746.

  • * Sharma M, Cornelius VR, Patel JP, Davies JG, Molokhia M. Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis. Circulation. 2015 Jul 21;132(3):194-204. doi: 10.1161/CIRCULATIONAHA.114.013267. Epub 2015 May 20. PMID: 25995317; PMCID: PMC4765082.

  • * Pan KL, Singer DE, Ovbiagele B, Wu YL, Ahmed MA, Lee M. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2017 Jul 18;6(7). doi: 10.1161/JAHA.117.005835. Epub 2017 Jul 18. PMID: 28720644; PMCID: PMC5586302.

  • * Proietti M, Romanazzi I, Romiti GF, Farcomeni A, Lip GYH. Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis. Stroke. 2018 Jan;49(1):98-106. doi: 10.1161/STROKEAHA.117.018395. Epub 2017 Nov 22. PMID: 29167388.

  • * Xu W, Lv M, Wu S, Jiang S, Zeng Z, Fang Z, Qian J, Chen M, Chen J, Zhang J. Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis. Cardiovasc Drugs Ther. 2023 Apr;37(2):363-377. doi: 10.1007/s10557-021-07232-9. Epub 2021 Aug 26. PMID: 34436708.

  • * Pokorney SD, Chertow GM, Al-Khalidi HR, Gallup D, Dignacco P, Mussina K, Bansal N, Gadegbeku CA, Garcia DA, Garonzik S, Lopes RD, Mahaffey KW, Matsuda K, Middleton JP, Rymer JA, Sands GH, Thadhani R, Thomas KL, Washam JB, Winkelmayer WC, Granger CB, RENAL-AF Investigators. Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial. Circulation. 2022 Dec 6;146(23):1735-1745. doi: 10.1161/CIRCULATIONAHA.121.054990. Epub 2022 Nov 6. PMID: 36335914.

  • * Lopes RD, Granger CB, Wojdyla DM, McIntyre WF, Alings M, Mani T, Ramasundarahettige C, Rivard L, Atar D, Birnie DH, Boriani G, Amit G, Leong-Sit P, Rinne C, Duray GZ, Gold MR, Hohnloser SH, Kutyifa V, Benezet-Mazuecos J, Cosedis Nielsen J, Sticherling C, Benz AP, Linde C, Kautzner J, Mabo P, Mairesse GH, Connolly SJ, Healey JS. Apixaban vs Aspirin According to CHA(2)DS(2)-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA. J Am Coll Cardiol. 2024 Jul 23;84(4):354-364. doi: 10.1016/j.jacc.2024.05.002. Epub 2024 May 19. PMID: 39019530.

  • * Tannu M, Lopes RD, Wojdyla DM, Goodman SG, Aronson R, Mehran R, Granger CB, Windecker S, Alexander JH, Jones WS. Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation: Insights From AUGUSTUS. J Am Coll Cardiol. 2025 Mar 25;85(11):1157-1168. doi: 10.1016/j.jacc.2024.10.125. Epub 2025 Feb 5. PMID: 39918467.

  • * Kamel H, Longstreth WT Jr, Tirschwell DL, Kronmal RA, Elkind MSV, Pauls Q, Garcia RA, Plummer P, Sabagha N, Ammar A, Healey JS, Shoamanesh A, Sheth KN, Broderick JP, Navi BB, ARCADIA Investigators. Apixaban Versus Aspirin and Risk of Hemorrhage in the ARCADIA Trial. Ann Neurol. 2026 Jun;99(6):1589-1597. doi: 10.1002/ana.78186. Epub 2026 Feb 25. PMID: 41741942.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.